Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;33(2):88-94.
doi: 10.5534/wjmh.2015.33.2.88. Epub 2015 Aug 19.

Risk Factors for Transient Urinary Incontinence after Holmium Laser Enucleation of the Prostate

Jong Kil Nam  1 , Hyeon Woo Kim  2 , Dong Hoon Lee  1 , Ji-Yeon Han  1 , Jeong Zoo Lee  2 , Sung-Woo Park  3
Affiliations

Risk Factors for Transient Urinary Incontinence after Holmium Laser Enucleation of the Prostate

Jong Kil Nam et al. World J Mens Health. 2015 Aug.

Abstract

Purpose: To investigate the factors associated with the occurrence of and recovery from transient urinary incontinence (TUI) after holmium laser enucleation of the prostate (HoLEP).

Materials and methods: From March 2009 to December 2012, 391 consecutive patients treated with HoLEP for benign prostatic hyperplasia were enrolled. Information regarding age, prostate volume, International Prostate Symptom Score, Overactive Bladder Symptom Score, peak urinary flow rate, postvoid residual urine, and operation time was collected. TUI was defined as a patient complaint of urine leakage, regardless of type. Logistic regression was used to investigate the factors associated with the occurrence of TUI, and the Kaplan-Meier test was used to analyze the TUI recovery period.

Results: TUI after HoLEP occurred in 65 patients (16.6%), 52 patients of whom (80.0%) showed recovery within three months. Stress and urge urinary incontinence and postvoid dribbling occurred in 16 patients (4.1%), 29 patients (7.4%), and 33 patients (8.4%), respectively. Age (odds ratio [OR]=3.494; 95% confidence interval [CI]=1.565~7.803; p=0.002) and total operation time (OR=3.849; 95% CI=1.613~9.185; p=0.002) were factors that significantly affected the occurrence of TUI.

Conclusions: TUI, defined as any type of urine leakage, occurred after HoLEP in some patients, most of whom recovered within three months. Stress urinary incontinence occurred in only 4% of patients after HoLEP. Age and total operation time were associated with the occurrence of postoperative TUI.

Keywords: Lasers; Prostatic hyperplasia; Urinary incontinence.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1. Recovery ratio of transient urinary incontinence depending on its duration. Eighty percent of the patients who complained transient urinary incontinence after holmium laser enucleation of the prostate showed recovery within 3 months from the date of the surgery (n=65).
See this image and copyright information in PMC

References

    1. Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol. 1998;12:457–459. - PubMed
    1. Kuntz RM, Lehrich K, Ahyai S. Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size. J Endourol. 2004;18:183–188. - PubMed
    1. Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH) Eur Urol. 2006;49:961–969. - PubMed
    1. Shah HN, Mahajan AP, Hegde SS, Bansal MB. Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int. 2007;100:94–101. - PubMed
    1. Lee MH, Yang HJ, Kim DS, Lee CH, Jeon YS. Holmium laser enucleation of the prostate is effective in the treatment of symptomatic benign prostatic hyperplasia of any size including a small prostate. Korean J Urol. 2014;55:737–741. - PMC - PubMed